Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- October 21, 2008 - November 04, 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study has been performed according to OECD and/or EC guidelines and according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- (1987)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- B508
- IUPAC Name:
- B508
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material: B508
- Physical state: powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Sprague Dawley strain (Crl:CD(SD))
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Source: Charles River Japan Inc. (3-17-6 Shinyokohama, Kouhoku, Yokohama, Kanagawa, Japan)
- Age at study initiation: Young adult animals (approx. 8 weeks old)
- Weight at study initiation: 252 to 258 g (male), 203 to 220 g (female)
- Housing: One animal per cage (wire-mesh stainless steel cage)
- Diet: Free access to pelleted diet MF (Lot No. 080820, 080522, Oriental Yeast Co., Ltd.)
- Water: Free access to tap water (filtered through a 5 µm cartidge filter and sterilized with an ultraviolet water sterilizer).
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.9 – 24.4
- Humidity (%): 45.3 - 61.7
- Air changes (per hr): 17
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- propylene glycol
- Details on dermal exposure:
- The hair of the back was removed with electric clipper and shaver on the previous day of administration. A piece of lint cloth (4x5 cm) moistened with the dosing material was directly on the administration site. The lint cloth was fixed by non-permeable adhesive tape and adhesive elastic bandage to improve adhesiveness.
Frequency: Single dosage, on Day 0.
Washing: After the contact period the patch was carefully removed and the treated skin wiped with cotton wool moistened with water for injection to remove any residual test substance. - Duration of exposure:
- 24 hours.
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- Dose volume: 10 mL/kg body weight
DOSAGE PREPARATION: To prepare a 20 w/v% formulation of the test substance, 7000 g of the test substance was weighed in a mortar and mixed with propylene glycol using a pestle and 35 mL was finally made in a brown volumetric tube.
Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Mortality/Viability: Twice daily
Body weights: Body weight of each animal was measured on the start day of application and on Days 1, 2, 3, 4, 7 and 14
Clinical signs: Observation was conducted continuously for one hour after the start of application and thereafter at 2, 3 and 6 hours on the start day of application and once a day from the following day.
- Necropsy of survivors performed: yes - Statistics:
- None.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred.
- Clinical signs:
- Although neither male nor female animals showed any abnormality in their appearance and behavior, there was bluish staining on the application sites and bluish feces 1 day (patch removal day) and 2 days (the next day after patch removal) after the start of application, respectively.
- Body weight:
- Reduction in body weight was observed in both sexes on the first day (patch removal day) when compared with the body weight just before treatment. But a satisfactory increase of the body weight was observed after the patch removal and the body weight gains during the observation period were 75 to 93 g in males and 40 to 63 g in females.
- Gross pathology:
- No abnormalities were observed in appearance, the organs and tissues in the cranial, thoracic and abdominal cavities, and lymph nodes in both sexes.
- Other findings:
- None.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In an acute dermal toxicity study with rats, performed according to OECD 402 guideline and GLP Principles, an LD50 >2000 mg/kg bw was determined.
- Executive summary:
B508 was administered to rats by a single dermal application at 2000 mg/kg bw for 24 hours according to OECD 402 guideline and GLP Principles.
No mortality occurred. No adverse clinical signs were observed. No effect on body weight gain after patch removal was noted. No macroscopic abnormalities were observed. The dermal LD50 of B508 in rats was established to exceed 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.